These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8024677)

  • 41. The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls.
    Palmer C; Ellis KA; O'Neill BV; Croft RJ; Leung S; Oliver C; Wesnes KA; Nathan PJ
    Hum Psychopharmacol; 2008 Mar; 23(2):151-9. PubMed ID: 17972276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of acute smoked marijuana on complex cognitive performance.
    Hart CL; van Gorp W; Haney M; Foltin RW; Fischman MW
    Neuropsychopharmacology; 2001 Nov; 25(5):757-65. PubMed ID: 11682259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans.
    Vitiello B; Martin A; Hill J; Mack C; Molchan S; Martinez R; Murphy DL; Sunderland T
    Neuropsychopharmacology; 1997 Jan; 16(1):15-24. PubMed ID: 8981385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats.
    Decker MW; Majchrzak MJ
    Psychopharmacology (Berl); 1992; 107(4):530-4. PubMed ID: 1603896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No role of beta receptors in cognitive flexibility: Evidence from a task-switching paradigm in a randomized controlled trial.
    Steenbergen L; Sellaro R; de Rover M; Hommel B; Colzato LS
    Neuroscience; 2015 Jun; 295():237-42. PubMed ID: 25818049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scopolamine challenges in Alzheimer's disease.
    Sunderland T; Tariot P; Murphy DL; Weingartner H; Mueller EA; Cohen RM
    Psychopharmacology (Berl); 1985; 87(2):247-9. PubMed ID: 3931154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential CNS effects of diazepam in elderly adults.
    Nikaido AM; Ellinwood EH; Heatherly DG; Dubow D
    Pharmacol Biochem Behav; 1987 Jun; 27(2):273-81. PubMed ID: 3628442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis.
    Dumas J; Hancur-Bucci C; Naylor M; Sites C; Newhouse P
    Horm Behav; 2008 Jan; 53(1):159-69. PubMed ID: 17964576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive performance, hyperoxia, and heart rate following oxygen administration in healthy young adults.
    Scholey AB; Moss MC; Neave N; Wesnes K
    Physiol Behav; 1999 Nov; 67(5):783-9. PubMed ID: 10604851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia.
    Howe MN; Price IR
    Int Psychogeriatr; 2001 Dec; 13(4):465-75. PubMed ID: 12003253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple-dose arecoline infusions in Alzheimer's disease.
    Tariot PN; Cohen RM; Welkowitz JA; Sunderland T; Newhouse PA; Murphy DL; Weingartner H
    Arch Gen Psychiatry; 1988 Oct; 45(10):901-5. PubMed ID: 3048224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of glucose on nonmemory cognitive functioning in the elderly.
    Allen JB; Gross AM; Aloia MS; Billingsley C
    Neuropsychologia; 1996 May; 34(5):459-65. PubMed ID: 8861236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of R 58 735 (Sabeluzole) on memory functions in healthy elderly volunteers.
    Clincke GH; Tritsmans L; Idzikowski C; Amery WK; Janssen PA
    Psychopharmacology (Berl); 1988; 94(1):52-7. PubMed ID: 3126527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naloxone's effect on cognitive functioning in drug-free and diazepam-treated normal humans.
    Wolkowitz OM; Tinklenberg JR
    Psychopharmacology (Berl); 1985; 85(2):221-3. PubMed ID: 3925486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose naloxone in older normal subjects: implications for Alzheimer's disease.
    Tariot PN; Gross M; Sunderland T; Cohen MR; Weingartner H; Murphy DL; Cohen RM
    J Am Geriatr Soc; 1988 Aug; 36(8):681-6. PubMed ID: 3042841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of atropine on the repeated acquisition and performance of response sequences in humans.
    Higgins ST; Woodward BM; Henningfield JE
    J Exp Anal Behav; 1989 Jan; 51(1):5-15. PubMed ID: 2921588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mecamylamine: new therapeutic uses and toxicity/risk profile.
    Young JM; Shytle RD; Sanberg PR; George TP
    Clin Ther; 2001 Apr; 23(4):532-65. PubMed ID: 11354389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-dependent action of glucose on memory processes in women: effect on serial position and recall priority.
    Messier C; Pierre J; Desrochers A; Gravel M
    Brain Res Cogn Brain Res; 1998 Oct; 7(2):221-33. PubMed ID: 9774737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presidential address, 1982. The pharmacology of human information processing.
    Callaway E
    Psychophysiology; 1983 Jul; 20(4):359-70. PubMed ID: 6356200
    [No Abstract]   [Full Text] [Related]  

  • 60. Glucose and mental performance.
    Bellisle F
    Br J Nutr; 2001 Aug; 86(2):117-8. PubMed ID: 11502223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.